Literature DB >> 22610366

Corticosterone regulates the expression of neuropeptide Y and reelin in MLO-Y4 cells.

Yuanyuan Ma1, Xiangnan Wu, Xianxian Li, Jing Fu, Jiefei Shen, Xiaoyu Li, Hang Wang.   

Abstract

Osteocytes that have a dendritic appearance are widely believed to form a complex cellular network system and play crucial roles in mechanotransduction as a principal bone mechanosensor, which is the basis of their neuronallike biology, as previously reported. Neuropeptide Y (NPY) and reelin mRNA, which are brain-specific neurogenic markers, have been identified in osteocytes. However, changes in the production of NPY and reelin in response to specific biochemical stimulation are unknown. In this study, we investigated the in vitro effect of corticosterone, one of the endogenous glucocorticoids, on the expression of NPY and reelin in the MLO-Y4 osteocyte cell line. Cells were treated with corticosterone at different concentrations (10(-9) M-10(-5) M) for 1, 3, 6, 12 and 24 h. As revealed, corticosterone reduced the MLO-Y4 cell viability and proliferation in a dose- and time-dependent manner based on an MTT assay and a Vi-CELL analyzer. The cells were then incubated with corticosterone (10(-6) μM), and the NPY and reelin expression levels were detected at 1, 3, 6, 12 and 24 h using real-time PCR and Western blot analysis. These results demonstrated that at the gene and the protein levels, corticosterone significantly upregulated the NPY and reelin expression in a time-dependent manner. The application of a glucocorticoid receptor antagonist, RU486, reversed the reduced cell viability and the increased expression of NPY and reelin that were caused by corticosterone. To the best of our knowledge, this is the first report to verify that corticosterone regulates the NPY and reelin expression in osteocytes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22610366      PMCID: PMC3887760          DOI: 10.1007/s10059-012-0053-y

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  44 in total

1.  Reelin binds alpha3beta1 integrin and inhibits neuronal migration.

Authors:  L Dulabon; E C Olson; M G Taglienti; S Eisenhuth; B McGrath; C A Walsh; J A Kreidberg; E S Anton
Journal:  Neuron       Date:  2000-07       Impact factor: 17.173

2.  Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells.

Authors:  N R Smalheiser; E Costa; A Guidotti; F Impagnatiello; J Auta; P Lacor; V Kriho; G D Pappas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Mechanosensation and Transduction in Osteocytes.

Authors:  Lynda F Bonewald
Journal:  Bonekey Osteovision       Date:  2006-10

Review 4.  Mechanotransduction in osteoblast regulation and bone disease.

Authors:  Katerina K Papachroni; Demetrios N Karatzas; Kostas A Papavassiliou; Efthimia K Basdra; Athanasios G Papavassiliou
Journal:  Trends Mol Med       Date:  2009-04-08       Impact factor: 11.951

5.  Different activation of ACTH and corticosterone release in response to various stressors in rats.

Authors:  J Djordjević; G Cvijić; V Davidović
Journal:  Physiol Res       Date:  2003       Impact factor: 1.881

6.  Early life stress stimulates hippocampal reelin gene expression in a sex-specific manner: evidence for corticosterone-mediated action.

Authors:  Claus M Gross; Armin Flubacher; Stefanie Tinnes; Andrea Heyer; Marie Scheller; Inga Herpfer; Mathias Berger; Michael Frotscher; Klaus Lieb; Carola A Haas
Journal:  Hippocampus       Date:  2010-12-06       Impact factor: 3.899

7.  ERK1/2 is involved in cyclic compressive force-induced IL-6 secretion in MLO-Y4 cells.

Authors:  Wenchuan Chen; Yuanyuan Ma; Hong Ye; Yun He; Xiaoyu Li; Jihua Li; Zhimin Zhu; Hang Wang
Journal:  Biochem Biophys Res Commun       Date:  2010-09-16       Impact factor: 3.575

8.  Estrogen facilitates both phosphatidylinositol 3-kinase/Akt and ERK1/2 mitogen-activated protein kinase membrane signaling required for long-term neuropeptide Y transcriptional regulation in clonal, immortalized neurons.

Authors:  Danny Titolo; Christopher M Mayer; Sandeep S Dhillon; Fang Cai; Denise D Belsham
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

9.  NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors.

Authors:  Liliana Teixeira; Daniela M Sousa; Ana Filipa Nunes; Mónica M Sousa; Herbert Herzog; Meriem Lamghari
Journal:  J Cell Biochem       Date:  2009-08-01       Impact factor: 4.429

10.  Demonstration of direct neurite-osteoclastic cell communication in vitro via the adrenergic receptor.

Authors:  Satoko Suga; Shigemi Goto; Akifumi Togari
Journal:  J Pharmacol Sci       Date:  2010-01-22       Impact factor: 3.337

View more
  4 in total

1.  Pax6 expressed in osteocytes inhibits canonical Wnt signaling.

Authors:  Ajita Jami; Jogeswar Gadi; Min Jung Lee; Eun Jin Kim; Mi Jeong Lee; Han-Sung Jung; Hong-Hee Kim; Sung-Kil Lim
Journal:  Mol Cells       Date:  2013-03-22       Impact factor: 5.034

2.  Reelin Expression in Creutzfeldt-Jakob Disease and Experimental Models of Transmissible Spongiform Encephalopathies.

Authors:  Agata Mata; Laura Urrea; Silvia Vilches; Franc Llorens; Katrin Thüne; Juan-Carlos Espinosa; Olivier Andréoletti; Alejandro M Sevillano; Juan María Torres; Jesús Rodríguez Requena; Inga Zerr; Isidro Ferrer; Rosalina Gavín; José Antonio Del Río
Journal:  Mol Neurobiol       Date:  2016-10-10       Impact factor: 5.590

3.  4-methoxychalcone enhances cisplatin-induced oxidative stress and cytotoxicity by inhibiting the Nrf2/ARE-mediated defense mechanism in A549 lung cancer cells.

Authors:  Juhee Lim; Sung Ho Lee; Sera Cho; Ik-Soo Lee; Bok Yun Kang; Hyun Jin Choi
Journal:  Mol Cells       Date:  2013-09-16       Impact factor: 5.034

4.  Intra-day variations of blood reelin levels in healthy individuals.

Authors:  Lukas Sturm; Ludger Tebartz van Elst; Bernd Fiebich; Martin Wolkewitz; Tobias Hornig
Journal:  Arch Med Sci       Date:  2019-12-31       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.